Cargando…

Efficacy evaluation of direct antiviral drugs against hepatitis B virus in improving the degree of liver fibrosis

INTRODUCTION: The aim of the study was to find an ideal index reflecting inflammation and fibrosis for patients after antiviral treatment, and compare it with imaging examination (liver stiffness measurement – LSM) and traditional liver fibrosis models (APRI and FIB-4). MATERIAL AND METHODS: A total...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miao, Liang, Cao, Lihua, Wang, Guiqiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2023
Materias:	Clinical Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10485686/ https://www.ncbi.nlm.nih.gov/pubmed/37692030 http://dx.doi.org/10.5114/ceji.2023.127621

Ejemplares similares

Gender as a factor affecting NK cell activity in patients successfully treated for chronic hepatitis C with direct-acting antivirals
por: Zientarska, Agata, et al.
Publicado: (2021)

The Functional and Antiviral Activity of Interferon Alpha-Inducible IFI6 Against Hepatitis B Virus Replication and Gene Expression
por: Sajid, Muhammad, et al.
Publicado: (2021)

Efficacy of Antiviral Treatment in Hepatitis C Virus (HCV)-Driven Monoclonal Gammopathies Including Myeloma
por: Rodríguez-García, Alba, et al.
Publicado: (2022)

Antiviral drugs against hepatitis C virus
por: Rehman, Sidra, et al.
Publicado: (2011)

Molnupiravir and Its Antiviral Activity Against COVID-19
por: Tian, Lili, et al.
Publicado: (2022)

Human γδ T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug Therapy
por: Ravens, Sarina, et al.
Publicado: (2018)

Efficacy of Hepatoprotective Agents With or Without Antiviral Drugs on Liver Function and Fibrosis in Patients With Hepatitis B: A Meta-Analysis
por: Long, Li-Hui, et al.
Publicado: (2015)

Direct-Acting Antiviral Treatment in Albanian Patients With Chronic Hepatitis C and Advanced Liver Fibrosis
por: Cuko, Liri, et al.
Publicado: (2022)

The efficacy and safety of direct-acting antiviral drugs in the management of hepatitis C virus-related arthritis
por: Alian, Samah M., et al.
Publicado: (2020)

Prevalence and Outcome of Serum Autoantibodies in Chronic Hepatitis C Patients Undergoing Direct-Acting Antiviral Treatment
por: Romano, Ciro, et al.
Publicado: (2022)

The Crosstalk Between Liver Sinusoidal Endothelial Cells and Hepatic Microenvironment in NASH Related Liver Fibrosis
por: Du, Wei, et al.
Publicado: (2022)

DWI - histology: a possible means of determining degree of liver fibrosis?
por: Verloh, Niklas, et al.
Publicado: (2018)

Predicting Early Viral Control under Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Using Pretreatment Immunological Markers
por: Hutchinson, James A., et al.
Publicado: (2018)

M2BPGi for assessing liver fibrosis in patients with hepatitis C treated with direct-acting antivirals
por: Saleh, Shereen A, et al.
Publicado: (2020)

HCV Cure With Direct-Acting Antivirals Improves Liver and Immunological Markers in HIV/HCV-Coinfected Patients
por: Brochado-Kith, Óscar, et al.
Publicado: (2021)

Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease
por: Tamaki, Nobuharu, et al.
Publicado: (2022)

γδT Cells Suppress Liver Fibrosis via Strong Cytolysis and Enhanced NK Cell-Mediated Cytotoxicity Against Hepatic Stellate Cells
por: Liu, Meifang, et al.
Publicado: (2019)

Efficacy of Antiviral Drugs against Feline Immunodeficiency Virus
por: Hartmann, Katrin, et al.
Publicado: (2015)

Effect of the change in antiviral therapy indication on identifying significant liver injury among chronic hepatitis B virus infections in the grey zone
por: Ren, Shan, et al.
Publicado: (2022)

Effectiveness of direct-acting antiviral drugs against hepatitis C virus: predictive factors of response to the treatment
por: Cárdaba-García, María E., et al.
Publicado: (2021)

Drug Delivery Strategies for Antivirals against Hepatitis B Virus
por: Singh, Latavia, et al.
Publicado: (2018)

Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents
por: Cossiga, Valentina, et al.
Publicado: (2022)

Association between SII and hepatic steatosis and liver fibrosis: A population-based study
por: Xie, Ruijie, et al.
Publicado: (2022)

An easy-to-use AIHF-nomogram to predict advanced liver fibrosis in patients with autoimmune hepatitis
por: Zhang, Zhiyi, et al.
Publicado: (2023)

Outcomes in Hepatitis C Positive Liver Transplantation: Timing of Direct-Acting Antiviral Treatment and Impact on Graft Fibrosis
por: Wellington, Jennifer, et al.
Publicado: (2021)

Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B
por: Heo, Ja Yoon, et al.
Publicado: (2018)

Real-world efficacy and safety of pangenotypic direct-acting antivirals against hepatitis C virus infection in Taiwan
por: Chang, Kao-Chi, et al.
Publicado: (2021)

Aspartate Aminotransferase to Platelet Ratio Index and Fibrosis-4 Index for Detecting Liver Fibrosis in Patients With Autoimmune Hepatitis: A Meta-Analysis
por: Dong, Bingtian, et al.
Publicado: (2022)

Advances in the development of antivirals for rotavirus infection
por: Jiang, Lin, et al.
Publicado: (2023)

Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus
por: Kanda, Tatsuo, et al.
Publicado: (2015)

Direct-acting antiviral agents against hepatitis C virus and lipid metabolism
por: Kanda, Tatsuo, et al.
Publicado: (2017)

Bomidin: An Optimized Antimicrobial Peptide With Broad Antiviral Activity Against Enveloped Viruses
por: Liu, Rongrong, et al.
Publicado: (2022)

A Systematic Review of Direct-Acting Antivirals for Hepatitis C in Advanced CKD
por: Balk, Ethan M., et al.
Publicado: (2022)

Liver FOXP3 and PD1/PDL1 Expression is Down-Regulated in Chronic HBV Hepatitis on Maintained Remission Related to the Degree of Inflammation
por: Germanidis, Georgios, et al.
Publicado: (2013)

Evaluation of fibrosis in chronic hepatitis C patients treated with direct-acting antivirals
por: Tufan, Ayse Gokcen, et al.
Publicado: (2020)

Direct-Acting Antiviral Treatment of HCV Infection Does Not Resolve the Dysfunction of Circulating CD8(+) T-Cells in Advanced Liver Disease
por: Vranjkovic, Agatha, et al.
Publicado: (2019)

Sustained Virologic Response with Direct Acting Antivirals in HIV Coinfected Hepatitis C Patients and Its Effect on Liver Fibrosis
por: Lebron, Dora, et al.
Publicado: (2017)

The value of platelet count in evaluating the degree of liver fibrosis in patients with chronic hepatitis B
por: Zhong, Li‐Kun, et al.
Publicado: (2020)

Liver elastography can predict degree of advanced fibrosis for autoimmune hepatitis in biochemical remission
por: Paranaguá‐Vezozzo, Denise Cerqueira, et al.
Publicado: (2023)

Inflammasomes and Pyroptosis of Liver Cells in Liver Fibrosis
por: Gan, Can, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_84ka92qq0sk1on5j9n07jme6s5